By Josh White
Date: Wednesday 04 Jun 2025
LONDON (ShareCast) - (Sharecast News) - Abingdon Health announced on Wednesday that it has deepened its strategic relationship with US-based diagnostics firm Find Out From Home (FOFH), appointing company president Chris Yates as a director of FOFH.
The AIM-listed rapid test developer and manufacturer holds a 19% stake in FOFH through a service-for-equity arrangement, and was supporting the US company's product development and regulatory efforts.
Abingdon and FOFH are currently working on gaining regulatory approval for four self-test kits targeting sexually transmitted diseases, under a $2m contract announced in December.
In addition, the two companies were collaborating on the development of a further three STD tests.
At 1030 BST, shares in Abingdon Health were down 2.43% at 6.83p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 6.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 9.00p |
52 Week Low | 5.25p |
Volume | 105,092 |
Shares Issued | 193.63m |
Market Cap | £12.10m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 14,035 @ 6.37p |
16:23 | 3,234 @ 6.37p |
12:56 | 212 @ 6.13p |
11:54 | 11 @ 6.49p |
11:00 | 3,500 @ 6.68p |
You are here: research